Impact of Lurasidone on Metabolic Parameters and Prolactin Levels Based on Differences of Psychiatric Diagnosis, Dosage, and Introducing Methods: An Observational Study
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD [...]
Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain—Part II
by Atmaram Yarlagadda, MD; Ganesh Acharya, MD, PhD, FRCOG; Jayaprada [...]
Brexpiprazole as a New Serotonin–Dopamine Receptor Modulator: Considering the Clinical Relevance for Metabolic Parameters and Prolactin Levels
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD [...]
Prolactin Levels After Switching to Paliperidone Palmitate in Patients with Schizophrenia
by Masaru Nakamura, MD, PhD; Takahiko Nagamine, MD, PhD; Goro [...]
Placental Barrier and Autism Spectrum Disorders: The Role of Prolactin and Dopamine on the Developing Fetal Brain
by Atmaram Yarlagadda, MD; Ganesh Acharya, MD, PhD, FRCOG; Jayaprada [...]
A Risperidone-Induced Prolactinoma Resolved when a Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report
by Gail T. Arcari, MEd; Asante K. Mendes, MD; and [...]
Baseline Serum Prolactin in Drug-naive, First-episode Schizophrenia and Outcome at Five Years: Is it a Predictive Factor?
by Amresh Shrivastava; Megan Johnston; Yves Bureau; and Nilesh [...]